ORAOV1 is amplified in oral squamous cell carcinoma
✍ Scribed by Flávia Caló Aquino Xavier; Camila Oliveira Rodini; Katiúcia Batista Silva Paiva; Maria Fernanda Souza Setúbal Destro; Patricia Severino; Raquel A. Moyses; Head; Neck Genome Project GENCAPO; Eloiza H. Tajara; Fabio Daumas Nunes
- Book ID
- 111255515
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 253 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0904-2512
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background Extracapsular spread (ECS) in the cervical lymph nodes represents the most significant adverse prognostic indicator in oral squamous cell carcinoma (OSCC). ## Methods In a consecutive cohort of OSCC treated by primary surgery, ECS was seen in 25% (101) of 400 patients.
## Abstract ## Background Apoptosis is a genetically programmed form of cell death, of which caspases are the central components. ## Methods By tissue microarray of 229 cases of oral squamous cell carcinoma (OSCC), we analyzed the immunoexpression of caspases 3, 6, 7, 8, 9, and 10. ## Results
## Abstract ## Objectives/Hypothesis: Previous studies have demonstrated a relationship between elevated serum squamous cell carcinoma (SCC) antigen (SCC‐Ag) levels and shorter survival in cancer patients. Few studies, however, have investigated the role of serum SCC‐Ag levels in oral SCC (OSCC).